
Ross Margulies
Articles
-
1 week ago |
mondaq.com | Erin Estey Hertzog |Ross Margulies |Adam Finkelstein |Patrick Brennan
On May 12, CMS released draft guidance outlining how the agency willimplement negotiation under the Inflation Reduction Act's (IRA)Medicare Drug Price Negotiation Program (the "Program")for initial price applicability year (IPAY) 2028. The guidance alsosets expectations for manufacturers and dispensing entities toeffectuate negotiated Maximum Fair Prices (MFPs) in IPAY 2026,2027, and 2028 and potentially renegotiate for IPAY 2028 the MFPsinitially negotiated for IPAY 2026 or 2027.
-
Jan 28, 2025 |
mondaq.com | Ross Margulies |Alexander Somodevilla |Steven Chen
Dyslexia is a neurobiological disorder affecting up toone in five children, including over 80% of those with learningdisabilities.1 Despite its widespreadprevalence, many children are not properly screened or tested andoften miss out on evidence-based interventions to address theassociated challenges.
-
Jan 28, 2025 |
mondaq.com | Steven Chen |Ross Margulies |Alexander Somodevilla
Dyslexia is a neurobiological disorder affecting up toone in five children, including over 80% of those with learningdisabilities. Despite its widespread prevalence, manychildren are not properly screened or tested and often miss out onevidence-based interventions to address the associated challenges.
-
Nov 28, 2024 |
jdsupra.com | Haider Andazola |Ross Margulies
This overview is excerpted from Manatt on Health, Manatt’s subscription service that provides in-depth insights and analysis focused on the legal, policy and market developments.
-
Nov 22, 2024 |
mondaq.com | Ross Margulies |Haider Andazola
On November 12, Johnson & Johnson (J&J) filed suit against the Health Resources and Services Administration (HRSA) in D.C. federal district court, arguing that the 340B statute explicitly provides flexibility for manufacturers to decide how to offer 340B pricing, either through upfront discounts or post-purchase rebates, and that HSRA has not prohibited such an arrangement through its agreement with manufacturers (known as the Pharmaceutical Pricing Agreement (PPA)).
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →